Agentix Corp. (AGTX)

↓ Download CSV

CIK 0001603345 · OTC · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31
Metric (FY)2025202420232022202120202019201820172016
Revenue$0$1.2K$1.2K$2.2K$43.1K
Cost of Revenue$0$561$561$1.4K$1.4K
Gross Profit$0$679$679$893$41.8K
Operating Income-$513.3K-$744.8K-$1.37M-$2.63M-$1.34M-$121.3K-$134.4K-$334.0K-$292.4K
Net Income-$567.0K-$585.2K-$1.37M-$2.63M-$1.34M-$132.7K-$42.79M-$381.1K-$295.6K
EPS (Diluted)$-0.01$-0.01$-0.05
Total Assets$100.3K$106.4K$261.4K$16.0K$51.2K$292.8K$93$2.3K$7.1K$1.3K
Total Liabilities$3.20M$2.67M$2.51M$1.09M$606.9K$69.3K$125.9K$55.4K$72.2K$3.7K
Shareholders' Equity-$3.10M-$2.56M-$2.25M-$1.08M-$555.7K$6.7K-$125.8K-$53.1K-$65.1K-$2.4K
Cash & Equivalents$12.4K$145$1.8K$242.8K$2.1K$3.7K$619
Operating Cash Flow-$125.1K-$110.4K-$88.5K-$25.2K-$421.0K-$62.0K-$51.6K-$76.4K-$12.6K
Shares Outstanding40.07M40.07M40.07M38.92M34.87M34.49M20.6K20.6K6.02M6.02M